河(he)(he)北天(tian)(tian)成(cheng)藥(yao)(yao)業(ye)(ye)(ye)股(gu)(gu)份有限(xian)(xian)(xian)公(gong)(gong)(gong)司始建于1970年,1998年由國有企(qi)業(ye)(ye)(ye)改(gai)制(zhi)(zhi)(zhi)為(wei)(wei)有限(xian)(xian)(xian)公(gong)(gong)(gong)司,是滄(cang)(cang)州市(shi)(shi)十家改(gai)制(zhi)(zhi)(zhi)企(qi)業(ye)(ye)(ye)之一,也是一家虧損企(qi)業(ye)(ye)(ye)改(gai)制(zhi)(zhi)(zhi)成(cheng)功的(de)企(qi)業(ye)(ye)(ye)。2010年3月改(gai)制(zhi)(zhi)(zhi)為(wei)(wei)股(gu)(gu)份有限(xian)(xian)(xian)公(gong)(gong)(gong)司,河(he)(he)北天(tian)(tian)成(cheng)藥(yao)(yao)業(ye)(ye)(ye)股(gu)(gu)份有限(xian)(xian)(xian)公(gong)(gong)(gong)司除母(mu)公(gong)(gong)(gong)司以外還下(xia)設兩個公(gong)(gong)(gong)司,即:“河(he)(he)北道恩藥(yao)(yao)業(ye)(ye)(ye)有限(xian)(xian)(xian)公(gong)(gong)(gong)司”,“河(he)(he)北天(tian)(tian)成(cheng)藥(yao)(yao)業(ye)(ye)(ye)股(gu)(gu)份有限(xian)(xian)(xian)公(gong)(gong)(gong)司滄(cang)(cang)州渤海分公(gong)(gong)(gong)司(河(he)(he)北諾特藥(yao)(yao)業(ye)(ye)(ye)有限(xian)(xian)(xian)公(gong)(gong)(gong)司)”,已形成(cheng)藥(yao)(yao)物(wu)研發、原料藥(yao)(yao)、制(zhi)(zhi)(zhi)劑(ji)全產(chan)業(ye)(ye)(ye)鏈,原料藥(yao)(yao)企(qi)業(ye)(ye)(ye)坐(zuo)落在臨港經(jing)濟開發區(qu)(qu),制(zhi)(zhi)(zhi)劑(ji)企(qi)業(ye)(ye)(ye)坐(zuo)落在滄(cang)(cang)州市(shi)(shi)經(jing)濟開發區(qu)(qu),是滄(cang)(cang)州市(shi)(shi)大(da)型的(de)綜合性制(zhi)(zhi)(zhi)藥(yao)(yao)企(qi)業(ye)(ye)(ye)。公(gong)(gong)(gong)司產(chan)品(pin)暢銷全國31個省市(shi)(shi)及地(di)區(qu)(qu),部(bu)分產(chan)品(pin)遠銷到東歐、東南(nan)亞、中亞、南(nan)美洲和非洲等(deng)30多(duo)個地(di)區(qu)(qu)和國家。
目(mu)前(qian),公司(si)現(xian)(xian)(xian)有職工1000多人、擁(yong)有碩(shuo)士(shi)研究生以上學歷人員60余人,大學生350余人,中高級專業職稱者(zhe)230人,專職質(zhi)檢人員120人。公司(si)在(zai)高速發(fa)展(zhan)(zhan)的(de)同(tong)(tong)時,一直大力發(fa)展(zhan)(zhan)新(xin)產(chan)品(pin)(pin)(pin)(pin)研發(fa)工作。目(mu)前(qian)已經成功(gong)投(tou)產(chan)的(de)新(xin)藥(yao)(yao)產(chan)品(pin)(pin)(pin)(pin)和國內仿(fang)制藥(yao)(yao)產(chan)品(pin)(pin)(pin)(pin)有:平衡鹽沖洗液、木糖(tang)醇(chun)氯(lv)化(hua)鈉(na)注射液(新(xin)藥(yao)(yao))、α-酮(tong)酸片、阿魏酸鈉(na)、注射用轉化(hua)糖(tang)、注射用磷酸肌(ji)酸鈉(na)、復方(fang)(fang)電解質(zhi)注射液等。目(mu)前(qian),公司(si)已經開發(fa)了新(xin)藥(yao)(yao)品(pin)(pin)(pin)(pin)種(zhong)3個(ge),仿(fang)制新(xin)藥(yao)(yao)20多個(ge),落戶(hu)產(chan)品(pin)(pin)(pin)(pin)16個(ge)。2019年,我公司(si)實現(xian)(xian)(xian)銷售收(shou)入近(jin)10億元,全年研發(fa)投(tou)入近(jin)3600萬元。目(mu)前(qian),公司(si)積(ji)極主動(dong)地謀求以脂質(zhi)體抗癌、心腦血管、腫(zhong)瘤、免疫調(diao)節(jie)等代謝類疾病用藥(yao)(yao)為(wei)開發(fa)的(de)方(fang)(fang)向(xiang),發(fa)展(zhan)(zhan)多劑型并存,大力發(fa)展(zhan)(zhan)無(wu)菌水(shui)(shui)針劑及無(wu)菌滴眼液。同(tong)(tong)時結合水(shui)(shui)針劑重點產(chan)品(pin)(pin)(pin)(pin)開發(fa)原(yuan)料藥(yao)(yao),實現(xian)(xian)(xian)從原(yuan)料到制劑的(de)產(chan)業鏈(lian)配套生產(chan),建(jian)立起品(pin)(pin)(pin)(pin)種(zhong)、技術與品(pin)(pin)(pin)(pin)牌優(you)勢(shi)。努力提高現(xian)(xian)(xian)有產(chan)品(pin)(pin)(pin)(pin)的(de)技術水(shui)(shui)平,降低成本,同(tong)(tong)時以現(xian)(xian)(xian)有生產(chan)設(she)施為(wei)依(yi)托(tuo),以市(shi)場需求為(wei)導向(xiang),積(ji)極尋求具有比(bi)較優(you)勢(shi)的(de)新(xin)產(chan)品(pin)(pin)(pin)(pin)。
公司生產大容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)射(she)(she)(she)(she)劑(ji)、小容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)射(she)(she)(she)(she)劑(ji)、粉(fen)針(zhen)劑(ji)、片(pian)劑(ji)、顆粒劑(ji)、膠囊劑(ji)等六個劑(ji)型(xing)近200種(zhong)產品(pin)和中藥提取物(wu)。我公司以大容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)射(she)(she)(she)(she)劑(ji)和小容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)射(she)(she)(she)(she)劑(ji)為主,做專業的(de)注(zhu)(zhu)射(she)(she)(she)(she)劑(ji)藥品(pin)生產商。大容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)射(she)(she)(she)(she)液產品(pin)齊全(quan),多種(zhong)包裝形式(shi)并(bing)存(cun),在PP瓶(ping)(ping)、軟袋、玻璃瓶(ping)(ping)輸液的(de)基礎上,向(xiang)雙室袋、多室袋等國際先進的(de)輸液包裝形式(shi)發展。小容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)射(she)(she)(she)(she)劑(ji)在玻璃安瓿(bu)的(de)基礎上,大力發展塑瓶(ping)(ping)(PP和PE)安瓿(bu)及西林(lin)瓶(ping)(ping)小水針(zhen)劑(ji)。積極謀求(qiu)國際高端(duan)GMP認證,由內銷為主向(xiang)內銷與出口并(bing)重轉變。